A treatable form of amnesia and rapid cognitive decline

QJM: An International Journal of Medicine

Volumn 102, Issue 2, 2009, Pages 145-146

  Ahmad, A ^a,c   Doran, M ^b  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CELL ANTIBODY; ETIRACETAM; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

AGED; AMNESIA; ANAMNESIS; ANTIBODY TITER; ARTICLE; BRAIN FUNCTION; CASE REPORT; COGNITIVE DEFECT; DEHYDRATION; ELECTROENCEPHALOGRAPHY; HUMAN; HYPERTENSION; INAPPROPRIATE VASOPRESSIN SECRETION; LUMBAR PUNCTURE; MALE; MEMORY DISORDER; MUSCLE TWITCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; SERUM OSMOLARITY; SODIUM BLOOD LEVEL; SYNCOPE; TONIC CLONIC SEIZURE; UNCONSCIOUSNESS; URINE OSMOLALITY; VISUAL HALLUCINATION;

EID: 58949104784     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcn143     Document Type: Article

References (3)

1. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50:73-8.
2. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005; 65:1730-6.
3. Theiben MJ, Lennon VA, Boeve BF, Aksamit AJ, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004; 62:1177-82.